Omeprazole treatment failure in gastroesophageal re fl ux disease and genetic variation at the cyp2c locus

HIGHLIGHTS

• who: GERD et al. from the Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand, Department of Medicine, University of Extremadura, Spain have published the research work: Omeprazole Treatment Failure in Gastroesophageal Re fl ux Disease and Genetic Variation at the CYP2C Locus, in the Journal: (JOURNAL)
• what: The authors investigate the association of ultrarapid metabolism induced by CYP2C19*17 and CYP2C:TG haplotypes with omeprazole treatment failure in refractory GERD. While further research in larger cohorts is necessary to replicate these observations, the study provides a preliminary insight into the clinical . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.